The joint UK National health Service (NHS) Greater Glasgow and University of Glasgow project, Glasgow Biomedicine, is part of ‘Medicine in Glasgow’, a unique collaboration aiming to develop and promote Glasgow as an international center of medical excellence.
The Glasgow Biomedicine project, which is supported by Scottish Enterprise Glasgow, is set to boost research and facilitate clinical trials in the city. It will attract commercial business to Glasgow and create a one-stop-shop for clinical expertise.
The trials are set to help sufferers of common diseases such as cardiovascular disease, diabetes, cancer, infectious diseases and neurological problems. The clinical trials organization will coordinate these activities across the city, with the aim of helping to deliver new treatments swiftly from laboratory bench to patient bedside.
As well as giving Glasgow residents access to revolutionary treatments for many diseases, it plans to attract large pharmaceutical and biotechnology companies and bring a number of highly skilled jobs to Scotland.
Health Minister, Andy Kerr, also announced that an additional GBP12.8 million will be provided for NHS R&D budgets over the next two years to support clinical trials.